About this trial
This study evaluates the clinical effectiveness of using a patient's own subepithelial connective tissue graft as a natural barrier membrane during simultaneous hard and soft tissue augmentation in areas of the jawbone with insufficient horizontal width. The procedure will be performed during delayed dental implant placement. The study aims to assess changes in hard and soft tissue dimensions and the clinical outcomes of this approach in patients with horizontally deficient alveolar ridges.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Presence of a single missing tooth with both neighboring teeth present
Patients at least 18 years of age
Good oral hygiene defined as full-mouth plaque score ≤25% (O'Leary, Drake, & Naylor, 1972)
Seibert class I defect at the single tooth gap as clinically assessed with buccopalatal bone dimension of at least 4 mm.
Disqualifiers
Pathological lesions (abscess-cyst-acute infection) in the defect site
Systemic diseases that would interfere with bone metabolism
Uncontrolled diabetic patients
Ongoing treatment or a history of recent chemotherapy or radiotherapy
Trial design
Single group
Treatments tested in this trial
Subepithelial Connective Tissue Graft as an Autogenous Barrier Membrane for Hard and Soft Tissue Augmentation in Horizontally Deficient Ridges during delayed implant placement
Procedure/Surgeryafter local anesthetic injection, patient received intrasulcular incision, intrasulcular incisions and vertical release incisions, full-thickness flap elevation was performed, autogenous bone collection was done from implant site then the implant placed; SCTG was harvested and placed as an autogenous barrier membrane over double layer of bone graft autogenous then Xeno graft followed by suturing
Treatment groups
Trial outcomes
Primary outcomes
Horizontal bone gain
Change in horizontal alveolar bone width from baseline to 6 months after implant placement, measured in millimeters (mm) using standardized radiographic assessment.
Secondary outcomes
change in buccal and crestal soft tissue thickness
Change in buccal and crestal soft tissue thickness at the implant site from baseline to 6 months after implant placement, measured in millimeters (mm).
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: